Navigation Links
Mother's immunosuppressive medications not likely to put fetus at risk
Date:11/8/2013

Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism.

The paper is one of the first to describe risks for medications used to treat autoimmune diseases when taken during pregnancy, according to first author William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and professor of Health Policy at Monroe Carell Jr. Children's Hospital at Vanderbilt in Nashville, Tenn.

"This study is important because these conditions affect nearly 4.5 million persons in the U.S., including many women of childbearing age," Cooper said. "Currently, there are almost no data to guide women who are pregnant, or planning to become pregnant, who may need to continue their medications during pregnancy."

Study authors used health plan data from Tennessee Medicaid, Kaiser Permanente Northern California and Southern California, linked with vital records and medical records. The three geographically diverse health plans collectively provide coverage for more than 8 million persons each year.

The cohort included 608 infants, including 437 with exposure during pregnancy and 171 whose mothers filled prescriptions for immunosuppressives before, but not during, pregnancy.

Women with rheumatoid and psoriatic arthritis, ankylosing spondylitis, lupus, scleroderma, and inflammatory bowel disease who filled prescriptions for immunosuppressive treatments during pregnancy were included in the study.

The drugs studied included hydroxychloroquine, tumor necrosis factor (TNF) inhibitors and other immunosuppressives such as sulfasalazine and azathioprine.

When compared with the women who had medication treatment before, but not during, pregnancy the risk ratios for adverse fetal outcomes associated with immunosuppressive use during pregnancy were not statistically significant, the authors reported.

Cooper said some of the medications in the study are relatively new and therefore haven't been extensively used in pregnancy. As use continues to expand, follow-up studies will be important to ensure that new safety signals aren't detected.

"One of the things we find in studying drug exposures in pregnancy is that, because up to 50 percent of pregnancies are unplanned, women may be taking a medication and become pregnant while still taking a potentially harmful drug," Cooper said. "Therefore, it's very important for women who have conditions that require medical treatments to talk with their providers about potential risks of medications in pregnancy."


'/>"/>

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Related medicine news :

1. Concerns about MRSA for expectant mothers may be unfounded
2. Low-Income Mothers May Overfeed Their Infants
3. Canadian teen moms run higher risk of abuse, depression than older mothers
4. Study finds that single mothers can reduce stress by playing, engaging with children
5. Study suggests poor mothers favor daughters
6. Making bad worse for expectant mothers
7. New hospital guidelines to help mothers at risk of postpartum depression
8. Lower iron levels seen in newborns of obese mothers
9. Babies Born to Obese Mothers May Have Low Iron: Study
10. Study Ties Infant Birth Weight to Mothers Breast Cancer Risk
11. Pregnant Mothers Gut Changes May Support Fetal Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2020)... TORONTO (PRWEB) , ... January 08, 2020 , ... ... the latest developments for a workplace of the future powered by the Myant ... technology demonstrations will highlight how an office environment connected to the Myant Platform ...
(Date:1/8/2020)... ... January 08, 2020 , ... Quality Health Care Concierge was founded ... and to maintain a comfortable and preferred lifestyle with their Companion Care services in ... care and has been a leader in the healthcare field for over a decade. ...
(Date:1/7/2020)... ... 2020 , ... Midmark Corp., a leading provider of medical, ... significantly impact the point of care ecosystem, where the majority of today’s healthcare ... patient is the most important aspect of the healthcare journey. Medical, dental and ...
(Date:1/7/2020)... ... January 07, 2020 , ... CBD For The People was ... the focus on the individual customer service experience. Transparency and integrity are the core ... profits second. By taking care of the people first, they know that satisfied customers ...
(Date:1/7/2020)... ... January 06, 2020 , ... After 32 years in Stealth Mode, ... LumaCare Duo ™. , The first public demonstrations of the LumaCare Duo will ... Vegas, Nevada during CES 2020, the largest consumer electronics trade show and conference in ...
Breaking Medicine News(10 mins):
(Date:1/7/2020)... ... ... Myant Inc., the pioneers in Textile Computing™, will be showcasing a line-up of ... 7-10, Las Vegas), including apparel from the Skiin Connected Health & Wellness line which ... 2020 Innovation Awards. , While electrocardiography, or the study of the electrical activity of ...
(Date:1/3/2020)... ... ... In Partnership with the Smiles for Everyone Foundation , Monarch ... TX office on February 8th. , Dental services provided include same-day procedures such as ... . For more information, please visit the Monarch Dental website . , ...
(Date:1/2/2020)... ... January 01, 2020 , ... In an age of the current mental ... call for community support to embrace acceptance and understanding of the needs of atypical’s ... Ethan’s Healthy Mind Express train, a new story that represents the Children’s First Mental ...
Breaking Medicine Technology: